Clinical Trials on This Study is to Understand the Current Practice of Sodium Management in Acute Neurological Injury in Canada
Total 0 results
Nothing found
Sponsors and Collaborators
- Nestlé Health Science Belgium
- Physip S.A
- Pedro Gamito
- Hospital Samaritano Paulista
- Markham Stouffville Hospital
- Familien Hede Nielsens Fond
- Advanced Life Solutions
- Braunschweig Integrated Centre of Systems Biology (BRICS), Germany
- UZ Leuven, campus Pellenberg (Belgium)
- Dr. Praveen B.H
- Custom Pharmaceuticals Limited
- IN-JET APS
- Universitatea de Medicina si Farmacie Iuliu Hatieganu
- The Fred Hollows Foundation, Australia
- Prof. Jacques SCHRENZEL
- Janssen (China) Research & Development Center
- Fogarty International Center of the National Institute of Health
- Stannah Stairlifts
- JMI Laboratories
- Hazelden Betty Ford Foundation
- View Full List
Medical Conditions
- Skull Base Neoplasms
- Pulmonary Adenocarcinoma
- Fracture Dislocation of Cervical Spine
- Gullian Barre Syndrome
- Spine Surgeries
- Chlamydophila Infections
- Epidemic Hemorrhagic Fever
- Tay-Sachs Disease Ganglioside
- Psoriasis, Arthritic
- Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
- Endocarditis Infective
- Painless Hysteroscopy
- Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
- Fetus or Neonate Affected by External Version Before Labor
- Multisystem Proteinopathy
- Closure; Foramen Ovale
- Childhood Langerhans Cell Histiocytosis
- Ewing's Family Tumors
- Cutaneous Leiomyomata With Uterine Leiomyomata
- Predictors of Atrial Fibrillation Recurrences
- View Full List
Drug Interventions
- Adapalene Gel 0.3%
- Redifferentiation with retinoid acid
- Cereport
- Palliative care group first-line scheme
- Azelastine hydrochloride (BAYR9258)
- Esomeprazole 40mg before
- Adriamycin
- Glimepiride
- Mocetinostat - Recommended Phase 2 Dose (70 mg)
- PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
- High dose pantoprazole infusion
- Estradiol+Drospirenone
- Neihulizumab
- Semapimod
- EFV +TVA
- Naltrexone 50 mg/day + Cognitive Behavioral Therapy
- Chemotherapeutic Agent
- Qingkailing injection 40 ml
- NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
- Vehicle
- View Full List
CROs by country
- Contract Research Organizations in Angola
- Contract Research Organizations in Azerbaijan
- Contract Research Organizations in Bahamas
- Contract Research Organizations in Bosnia & Herzegovina
- Contract Research Organizations in Chile
- Contract Research Organizations in Ecuador
- Contract Research Organizations in Israel
- Contract Research Organizations in Kuwait
- Contract Research Organizations in Latvia
- Contract Research Organizations in Morocco
- Contract Research Organizations in Netherlands
- Contract Research Organizations in Panama
- Contract Research Organizations in Portugal
- CRO list by country